Form C: Issuer Information

Issuer Information

Name of Issuer:

Bioverge, Inc.

Check box if Amendment is material and investors will have five business days to reconfirm

Describe the Nature of the Amendment:

adding disclosures around issuer's promotional efforts. Adding a 20% discount, and changing the valuation cap to $18M for the first 635k raised, then the cap changes to $25M for remaining amount up to the max raised.

Legal Status of Issuer:

Form:

Corporation

Jurisdiction of Incorporation/Organization:

DELAWARE

Date of Incorporation/Organization:

08-17-2017

Physical Address of Issuer:

Address 1:

447 SUTTER ST

Address 2:

STE 405

City:

SAN FRANCISCO

State/Country:

CALIFORNIA

Mailing Zip/Postal Code:

94108

Website of Issuer:

https://bioverge.com/

Is there a Co-issuer?

Yes

Intermediary through which the Offering will be Conducted:

CIK:

0001751525

Company Name:

OpenDeal Portal LLC

Commission File Number:

007-00167

CRD Number:

283874

Form C: Offering Information

Offering Information

Amount of compensation to be paid to the intermediary, whether as a dollar amount or a percentage of the offering amount, or a good faith estimate if the exact amount is not available at the time of the filing, for conducting the offering, including the amount of referral and any other fees associated with the offering:

At the conclusion of the Offering, the Issuer shall pay the Intermediary a fee of six percent (6%) of the dollar amount raised in the Offering.

Any other financial interest in the issuer held by the intermediary, or any arrangement for the intermediary to acquire such an interest:

The Intermediary will also receive compensation in the form of securities equal to two percent (2%) of the total number of the securities sold in the Offering.

Type of Security Offered:

Other

Specify:

Crowd SAFE (Simple Agreement for Future Equity)

Target Number of Securities to be Offered:

25000

Price:

1.00000

Price (or Method for Determining Price):

Arbitrary

Target Offering Amount:

25000.00

Maximum Offering Amount (if different from Target Offering Amount):

1235000.00

Oversubscriptions Accepted:

Yes

If yes, disclose how oversubscriptions will be allocated:

Other

Provide a description:

Other: At the Intermediary's discretion

Deadline to reach the Target Offering Amount:

08-07-2023

NOTE: If the sum of the investment commitments does not equal or exceed the target offering amount at the offering deadline, no securities will be sold in the offering, investment commitments will be cancelled and committed funds will be returned.

Form C: Annual Report Disclosure Requirements

Annual Report Disclosure Requirements

Current Number of Employees:

2.00

Total Assets Most Recent Fiscal Year-end:

567769.00

Total Assets Prior Fiscal Year-end:

751759.00

Cash and Cash Equivalents Most Recent Fiscal Year-end:

324314.00

Cash and Cash Equivalents Prior Fiscal Year-end:

487668.00

Accounts Receivable Most Recent Fiscal Year-end:

0.00

Accounts Receivable Prior Fiscal Year-end:

0.00

Short-term Debt Most Recent Fiscal Year-end:

52668.00

Short-term Debt Prior Fiscal Year-end:

178120.00

Long-term Debt Most Recent Fiscal Year-end:

0.00

Long-term Debt Prior Fiscal Year-end:

0.00

Revenue/Sales Most Recent Fiscal Year-end:

247786.00

Revenue/Sales Prior Fiscal Year-end:

251720.00

Cost of Goods Sold Most Recent Fiscal Year-end:

49972.00

Cost of Goods Sold Prior Fiscal Year-end:

26101.00

Taxes Paid Most Recent Fiscal Year-end:

0.00

Taxes Paid Prior Fiscal Year-end:

0.00

Net Income Most Recent Fiscal Year-end:

-406203.00

Net Income Prior Fiscal Year-end:

-591903.00